Versius

What it's for

Versius is used for robot-assisted laparoscopic surgery, that is, operations in which the surgeon works through small incisions, looking at a three-dimensional HD image and controlling instruments from a console. Versius takes a different route from the dominant da Vinci: instead of one big cart, it has modular, independent arms that staff wheel into a standard room without rebuilding it. The characteristic element is the patented V-Wrist joint with full 360-degree rotation. The manufacturer designed it to preserve the laparoscopic port layout that surgeons know, which is meant to shorten the learning curve compared with the competition. The robot has seven degrees of freedom, and its sensing includes 3D HD imaging and, since one of the updates, ICG fluorescence for assessing tissue perfusion. The application is robot-assisted laparoscopic surgery; the manufacturer's sources do not list specialties in detail, so we do not invent our own list. The general picture of robotic surgery in Poland is covered in “da Vinci Robots in Polish Hospitals”, from urology through general surgery to gynecologic oncology. This is equipment for the hospital setting only, and it falls under medical device regulations, not industrial robot standards. Its strengths are a smaller footprint in the room and the mobility of individual arms. On the weaker side, the scale of clinical references and the installed base are smaller than at the leader, da Vinci 5.

Who it's for

Worth considering for: hospitals that want to enter robotic surgery but have limited space or want to serve more rooms with a single set; centers that value flexible arm placement and a familiar port layout. Interested parties must verify regulatory approval in their own country: the system is approved for use in Europe, Australia and Brazil.

Who it is not for: a patient or facility looking for a “ready price”; the manufacturer does not state the system price or the cost of a single procedure, and a purchase decision means a tender and a long clinical analysis. Clinics whose surgeons are trained mainly on da Vinci and do not want to change platform. Neither this text nor our site is medical advice; the choice of surgical method is decided by the doctor. Facilities assessing availability in Poland should consult the overview in “da Vinci Robots in Polish Hospitals”.

Deployments

According to the manufacturer, more than 20,000 procedures had been performed with Versius by 2024, and the system is approved in Europe, Australia and Brazil. That is the only figure we treat as confirmed; we have no list of hospitals. In Poland, Versius is counted in the overview of robotic surgery systems alongside da Vinci, Hugo and Edge Medical, with over 100 installations in total as of January 2026, though Versius's share is not broken out. We have not confirmed specific facilities with Versius, so we give no names. No confirmed, named deployments in Poland; the national context is in “da Vinci Robots in Polish Hospitals” and in the category “Specialist robots”.

da Vinci 5: the fifth generation of the da Vinci system from Intuitive Surgical, the market leader with the longest clinical history and the largest number of trained surgeons. No public price. Choose it when clinical track record counts.

Hugo (Medtronic): a robotic surgery system from Medtronic plc (Hugo RAS); in our catalog it appears as a manufacturer without a separate model page. It is mentioned alongside Versius in the Polish overview in “da Vinci Robots in Polish Hospitals”.

Edge Medical (MP1000): a Chinese system named among the competitors in Poland; we do not have a model page for it in the catalog, so we do not assess details.

Devanthro Robody is a different category, a teleoperated humanoid for care, but it shows where medical robotics reaches beyond the operating room. Choosing a surgical platform is a clinical and procurement decision, so compare systems on references, training, service and the cost of single-use instruments, not only on the design of the arms.

Versius was presented in September 2018, and according to the company's chronology the market launch came in 2019, the year CMR Surgical reached unicorn status. The company was founded in 2014 in Cambridge, and production takes place in Ely in Cambridgeshire. In its 2021 Series D round CMR raised 600 million USD at a 3 billion USD valuation.

By 2024 more than 20,000 procedures had been performed with the system, and the British factory can produce up to 500 systems a year. Competition is growing: alongside da Vinci 5, Hugo and the Chinese Edge Medical have appeared. The company's history is expanded in the manufacturer profile CMR Surgical.